Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review

CONCLUSIONS: Breast cancer CE literature scarcely represents low-and-middle-income countries' perspectives and is influenced by pharmaceutical industry funding which targets European countries', frequently utilizes comparisons within same-drug class, and is more likely to have favorable conclusions.PMID:38603837 | DOI:10.1016/j.breast.2024.103727

Source: Breast - April 11, 2024 Category: Cancer & Oncology Authors: Felippe Lazar Neto Marina Acevedo Zarzar de Melo Cassio Murilo Trovo Hidalgo Filho Maria Cec ília Mathias-Machado Laura Testa Alessandro Gon çalves Campolina Source Type: research